| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |